CATALYST PHARMACEUTICALS, INC.: 10-Q filed 2017-08-09

Name: CATALYST PHARMACEUTICALS, INC.: 10-Q filed 2017-08-09
Creator: CATALYST PHARMACEUTICALS, INC.

What CATALYST PHARMACEUTICALS, INC. reported in its quarterly report filed 2017-08-09 (fiscal Q2 2017): 27 published measures, 75 facts as tagged in accession 0001193125-17-252800.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-08-09
Fiscal period: fiscal Q2 2017
Accession: 0001193125-17-252800 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CATALYST PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-06-30	35,980,125	USD
At 2016-12-31	41,706,853	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-06-30	2,010,944	USD
At 2016-12-31	2,397,923	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-06-30	33,969,181	USD
At 2016-12-31	39,308,930	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-06-30	8,583,727	USD
At 2016-12-31	13,893,064	USD
At 2016-06-30	18,717,104	USD
At 2015-12-31	28,235,016	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-3,879,901	USD	91
2017-01-01 to 2017-06-30	-8,847,030	USD	181
2016-04-01 to 2016-06-30	-4,568,914	USD	91
2016-01-01 to 2016-06-30	-9,955,151	USD	182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-01-01 to 2016-06-30	88,929	USD	182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-06-30	-116,995,100	USD
At 2016-12-31	-108,148,070	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2017-04-01 to 2017-06-30	USD	91
2017-01-01 to 2017-06-30	USD	181
2016-04-01 to 2016-06-30	USD	91
2016-01-01 to 2016-06-30	USD	182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-06-30	218,289	USD
At 2016-12-31	244,204	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	638,569	USD	91
2017-01-01 to 2017-06-30	1,392,713	USD	181
2016-04-01 to 2016-06-30	357,269	USD	91
2016-01-01 to 2016-06-30	815,238	USD	182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-4,181,271	USD	91
2017-01-01 to 2017-06-30	-8,861,142	USD	181
2016-04-01 to 2016-06-30	-4,814,452	USD	91
2016-01-01 to 2016-06-30	-11,051,988	USD	182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-06-30	35,752,948	USD
At 2016-12-31	41,453,761	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-06-30	1,840,425	USD
At 2016-12-31	2,094,535	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-06-30	692,345	USD
At 2016-12-31	933,176	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	4,181,271	USD	91
2017-01-01 to 2017-06-30	8,861,142	USD	181
2016-04-01 to 2016-06-30	4,814,452	USD	91
2016-01-01 to 2016-06-30	11,051,988	USD	182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	2,451,751	USD	91
2017-01-01 to 2017-06-30	5,265,680	USD	181
2016-04-01 to 2016-06-30	2,508,897	USD	91
2016-01-01 to 2016-06-30	6,055,288	USD	182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-06-30	84,554,979	shares
At 2016-12-31	82,972,316	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-06-30	150,879,726	USD
At 2016-12-31	147,374,028	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2017-06-30	357,684	USD
At 2016-12-31	357,684	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2017-06-30	139,395	USD
At 2016-12-31	113,480	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-06-30	1,148,080	USD
At 2016-12-31	1,161,359	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2017-06-30	621,558	USD
At 2016-12-31	1,047,944	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-3,879,901	USD	91
2017-01-01 to 2017-06-30	-8,847,030	USD	181
2016-04-01 to 2016-06-30	-4,568,914	USD	91
2016-01-01 to 2016-06-30	-9,955,151	USD	182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	1,729,520	USD	91
2017-01-01 to 2017-06-30	3,595,462	USD	181
2016-04-01 to 2016-06-30	2,305,555	USD	91
2016-01-01 to 2016-06-30	4,996,700	USD	182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	12,957	USD	91
2017-01-01 to 2017-06-30	25,915	USD	181
2016-04-01 to 2016-06-30	8,762	USD	91
2016-01-01 to 2016-06-30	21,960	USD	182

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	91,039	USD	91
2017-01-01 to 2017-06-30	201,016	USD	181
2016-04-01 to 2016-06-30	92,755	USD	91
2016-01-01 to 2016-06-30	210,698	USD	182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	-240,831	USD	181
2016-01-01 to 2016-06-30	-1,086,835	USD	182

Inspect the source

Entity: CATALYST PHARMACEUTICALS, INC. / CIK 0001369568
Captured: 2026-09-21T17:19:25.463Z
SEC response SHA-256: 7cf76a511a9127dd31ed7d53955bbe348f790d8d7fd354d359e6674e7b2af9c9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001369568.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))